Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy

Conclusions
CS are superior to TMX in treating iRPF disease. However, in patients with initial treatment success with primary treatment, recurrence rate was lower in TMX-treated patients.

Source: CKJ: Clinical Kidney Journal - March 15, 2016 Category: Urology & Nephrology Authors: van der Bilt, F. E., Hendriksz, T. R., van der Meijden, W. A. G., Brilman, L. G., van Bommel, E. F. H. Tags: RARE DISEASES Source Type: research